DOJ DOJ Withdraws Appeal of Copay Assistance Ruling Thomas Sullivan Mar 8, 2024 0 The United States Department of Justice (DOJ) recently agreed to withdraw its appeal of the ruling by the United States Court of…
DOJ Cross-Governmental RFI Seeking Input on Private Equity in Health Care Thomas Sullivan Mar 7, 2024 0 On March 5, 2024, several federal agencies issued a Request for Information (RFI) requesting public comments on deals that are…
Guidelines ONC Finalizes Changes to Information Blocking Rules Thomas Sullivan Mar 6, 2024 0 On December 13, the Office of the National Coordinator for Health Information Technology (ONC) finalized changes to the…
Medicare The Inflation Reduction Act Impact on Medicare Part D Thomas Sullivan Mar 5, 2024 0 Medicare’s Part D benefit is significantly impacted by the Inflation Reduction Act (IRA). The current Coverage Gap Discount…
DOJ Navigating the Future of Speaker Programs: Insights and Compliance… Thomas Sullivan Mar 4, 2024 0 The InformaConnect Speakers Program Summit, held from February 26-28, 2024, at Hilton Penn's Landing in Philadelphia, PA, served…
Events Unveiling the 21st Annual Pharmaceutical Compliance Congress: A Convergence… Thomas Sullivan Mar 1, 2024 0 As the pharmaceutical industry navigates an era marked by unparalleled change, the 21st Annual Pharmaceutical Compliance Congress…
Anti Kickback Former Pharmacy Operator Sentenced to Three Years in Prison for… Thomas Sullivan Feb 29, 2024 0 Recently, Elan Yaish was sentenced to three years in prison for his role in a health care kickback conspiracy involving…
DOJ Former Medical Device Manufacturing Employee Sentenced to Prison for… Thomas Sullivan Feb 28, 2024 0 A former employee of a medical device manufacturing company was recently sentenced to 12 months in prison and one year of…
FDA FDA Issues First Untitled Letter of 2024 Thomas Sullivan Feb 27, 2024 0 The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) recently issued the first…
FDA FDA Releases Finalized Guidance on Use of Real-World Data in New Drug and… Thomas Sullivan Feb 26, 2024 0 Recently, the United States Food and Drug Administration (FDA) finalized two guidance documents that outline how sponsors can use…